Radioiodine-131 is a therapeutic agent used in the management and treatment of hyperthyroidism and thyroid carcinoma. This activity describes the indications, mechanism of action, and contraindications for radioiodine-131 as a treatment for Graves disease, toxic adenoma, toxic multinodular goiter, and differentiated thyroid carcinoma. This activity will highlight information pertinent to members of the interprofessional healthcare team in the use of radioiodine-131 therapy.

**Objectives:**
- Identify the specific indications of 131-Iodine in the treatment of differentiated thyroid cancer and benign thyroid conditions. 
- Outline the adverse effects of 131-Iodine in the treatment of differentiated thyroid cancer and benign thyroid conditions. 
- Identify the absolute contraindications for 131-Iodine in the treatment of differentiated thyroid cancer and benign thyroid conditions.
- Summarize the importance of collaboration and communication amongst the interprofessional team to improve outcomes for patients receiving I-131.